Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...

Results from the Phase II C-144-01 trial showed that a single infusion of Amtagvi demonstrated a 31.4% objective response ...

Skin cancer is often overlooked by many Americans, who are at elevated risk for being over exposed to the sun in the summer ...

Results from the Phase III VERITAC-2 trial demonstrated that vepdegestrant reduced the risk of disease progression or death ...

Approval was based on results from the Phase III ARANOTE trial, in which Nubeqa demonstrated a 46% reduction in the risk of ...

Fidelis Care announced that it is using Men’s Health Month as an opportunity to promote important health tips that men should ...

The drinks contain a mix of protein and vitamins that will help GLP-1 users reduce weight in a healthy manner.

These diseases require specialty treatment typically unavailable at local retail pharmacies or small health systems, making ...

New drug application submission was based on positive data from the Phase III GLISTEN trial, which demonstrated significant ...

Results from the Phase III AMPLITUDE trial of niraparib plus abiraterone acetate and prednisone demonstrated a statistically significant and clinically meaningful improvement in patients with ...

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

Approval was based on data from the Phase III NextCOVE trial, which demonstrated that mNEXSPIKE met non-inferiority criteria ...